Diferencia entre revisiones de «Chloramphenicol»
(format change) |
(Remove disease-specific entries now covered by AntibioticDose (1 sections)) |
||
| (No se muestran 15 ediciones intermedias de 8 usuarios) | |||
| Línea 1: | Línea 1: | ||
==General== | ==General== | ||
*Type: bacteriostatic | *Type: bacteriostatic [[antibiotic]] | ||
*Dosage Forms: IV, IM, eye drops | *Dosage Forms: IV, IM, eye drops | ||
*Common Trade Names:pentamycetin, chloromycetin | *Common Trade Names: pentamycetin, chloromycetin | ||
==Adult Dosing== | ==Adult Dosing== | ||
===Infection, General=== | ===Infection, General=== | ||
*50- | *50-100mg/kg/day IV divided q6h | ||
=== | ===Indications by Disease=== | ||
{{#ask: [[Has DrugName::Chloramphenicol]] [[Has Population::Adult]] | |||
|?Treats disease=Disease | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|format=table | |||
|limit=50 | |||
|mainlabel=- | |||
|headers=show | |||
|sort=Treats disease | |||
}} | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
=== | |||
===Indications by Disease=== | |||
{{#ask: [[Has DrugName::Chloramphenicol]] [[Has Population::Pediatric]] | |||
|?Treats disease=Disease | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|format=table | |||
|limit=50 | |||
|mainlabel=- | |||
|headers=show | |||
|sort=Treats disease | |||
}} | |||
==Special Populations== | ==Special Populations== | ||
*Pregnancy: | *Pregnancy: Category C (risk not ruled out) | ||
*Lactation: | *Lactation: passes into breast milk and should be avoided if possible | ||
*Renal Dosing | *Renal Dosing: minimally excreted via kidneys | ||
**Adult | **Adult: amount not defined | ||
**Pediatric | **Pediatric: amount not defined | ||
*Hepatic Dosing | *Hepatic Dosing: metabolized by the liver, therefore dose must be reduced | ||
**Adult | **Adult: amount not defined | ||
**Pediatric | **Pediatric: amount not defined | ||
==Contraindications== | ==Contraindications== | ||
| Línea 31: | Línea 50: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*[[aplastic anemia]] | |||
*agranulocytosis | |||
*[[thrombocytopenia]] | |||
*[[anaphylaxis]] | |||
*gray baby syndrome | |||
*pseudomembranous colitis | |||
===Common=== | ===Common=== | ||
*headache | |||
*nausea, vomiting | |||
*diarrhea | |||
*fever | |||
*rash | |||
*urticaria | |||
*peripheral neuropathy | |||
*blurred vision | |||
==Pharmacology== | ==Pharmacology== | ||
*Half-life: | *Half-life: 1.5 - 4.1 hours | ||
*Metabolism: | *Metabolism: Liver | ||
*Excretion: | *Excretion: Urine | ||
*Mechanism of Action: | *Mechanism of Action: binds to 50S ribosomal subunit inhibiting protein synthesis | ||
==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== | ==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== | ||
| Línea 165: | Línea 198: | ||
*[[Antibiotics (Main)]] | *[[Antibiotics (Main)]] | ||
== | ==References== | ||
<references/> | |||
[[Category:Pharmacology]] [[Category:ID]] | |||
[[Category: | |||
Revisión actual - 11:08 20 mar 2026
General
- Type: bacteriostatic antibiotic
- Dosage Forms: IV, IM, eye drops
- Common Trade Names: pentamycetin, chloromycetin
Adult Dosing
Infection, General
- 50-100mg/kg/day IV divided q6h
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Bacterial conjunctivitis | 0.5% ophthalmic solution 1 drop QID for 7 days | Bacterial Conjunctivitis, Topical |
| Plague | 25mg/kg PO q6hrs | Postexposure prophylaxis age over 2 only |
| Rocky mountain spotted fever | 50-100mg/kg/day div q6hrs (max 4g/day) | Preferred in pregnancy |
| Tularemia | 15mg/kg IV q6hrs x 14 days | Active disease |
Pediatric Dosing
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Plague | 25mg/kg PO/IV q6hrs (max 4g/day); age >2 only | Pediatric Prophylaxis |
| Rocky mountain spotted fever | 50-100mg/kg/day IV divided q6hrs (max 4g/day) | Pediatric Doxycycline Allergy |
Special Populations
- Pregnancy: Category C (risk not ruled out)
- Lactation: passes into breast milk and should be avoided if possible
- Renal Dosing: minimally excreted via kidneys
- Adult: amount not defined
- Pediatric: amount not defined
- Hepatic Dosing: metabolized by the liver, therefore dose must be reduced
- Adult: amount not defined
- Pediatric: amount not defined
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- aplastic anemia
- agranulocytosis
- thrombocytopenia
- anaphylaxis
- gray baby syndrome
- pseudomembranous colitis
Common
- headache
- nausea, vomiting
- diarrhea
- fever
- rash
- urticaria
- peripheral neuropathy
- blurred vision
Pharmacology
- Half-life: 1.5 - 4.1 hours
- Metabolism: Liver
- Excretion: Urine
- Mechanism of Action: binds to 50S ribosomal subunit inhibiting protein synthesis
Antibiotic Sensitivities[1]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2014
